期刊文献+

丙型肝炎病毒蛋白酶抑制肽构建及活性的初步鉴定 被引量:3

Study on the expression of a substrate-based polypeptide and its inhibition against HCV protease in vitro
原文传递
导出
摘要 目的根据丙型肝炎病毒(HCV)丝氨酸蛋白酶4个多肽底物切点的氮基酸序列特异性,设计1个多位点的竞争性抑制多肽序列。方法采用中心模板法PCR合成多肽基因;利用原核高效表达载体pBVIL1在大肠杆菌HB101中。表达目的多肽;提取包涵体,用离子交换层析纯化蛋白;在体外添加到蛋白酶和NSSA—B片段构建的反应系统中。用SDS—PAGE鉴定多肽对病毒蛋白酶的抑制活性。结果正确合成了多肽基因,重组载体pBVIL1/IP在HB101中表达了目的多肽;纯化后,获得电泳纯多肽;体外初步测定证实,随多肽浓度增加,蛋白酶底物降解受到抑制。结论原核表达的重组抑制多肽,体外对HCV蛋白酶活性具有抑制作用。 Objective To synthesize an inhibitory peptide against serine protease of hepatitis C virus (HCV) and explore its inhibition ability in vitro. Methods Based on the sequence characteristics of four natural substrates of protease in HCV, the gene sequence of an inhibitory peptide against HCV serine protease was designed and directly synthesized by PCR. The segment was subcloned into prokaryotic expression vector pBVIL1, resulting in the construction of the recombinant plasmid pBVIL1/IP, which was then transformed into E. coli HB101 strain. Purified by ion exchange chromatography, the expressed protein was added into an in vitro system, which was comprised of the inhibitory peptide ( expressed protein), protease and the substrate, i.e. a NSSA-B fragment, in phosphate buffer. Then SDS-PAGE was performed to test the inhibition effect of the polypeptide. Results The recombinant expression vector pBVIL1/IP containing target gene was successfully constructed. The peptide expressed as inclusion body was identified by SDSPAGE. The degradation of protease substrate NSSA-B fragment is inhibited proportionally with the increasing concentrations of the peptide. Conclusion The recombinant peptide shows inhibitory effect on HCV protease in vitro.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2008年第2期119-122,共4页 Chinese Journal of Microbiology and Immunology
关键词 丙型肝炎病毒 NS3蛋白酶 多肽 抑制作用 Hepatitis C virns(HCV) NS3 protease Polypeptide Inhibition
  • 相关文献

参考文献10

  • 1Bartenschlager R. The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy. J Viral Hepat, 1999, 6(3): 165-181. 被引量:1
  • 2Steinkuhler C, Koch U, Narjes F, et al. Hepatitis C virus protease inhibitors: current progress and future challenges. Curr Med Chem, 2001, 8(8) : 919-932. 被引量:1
  • 3Ueno T, Misawa S, Ohba Y, et al. Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease. J Virol, 2000, 74(14): 6300-6308. 被引量:1
  • 4Fukuda K, Vishnuvardhan D, Sekiya S, et al. Isolation and characterization of RNA aptamers specific for the hepatitis C virus non-structural protein 3 protease. Eur J Biochem, 2000, 267 ( 12 ) : 3685 -3694. 被引量:1
  • 5Heintges T, Encke J, zu Putlitz J, et al. Inhibition of hepatitis C virus NS3 function by antisense oligodeoxynueleotides and protease inhibitor. J Med Virol, 2001, 65(4):671-680. 被引量:1
  • 6宋晓国,凌世淦,张贺秋,陈坤,孙柯儿,朱翠侠.高效原核融合表达载体(pBVIL1)的构建及在HCV抗原表达中的应用[J].细胞与分子免疫学杂志,2001,17(3):231-233. 被引量:34
  • 7胡巍,凌世淦,宋晓国,刘文,何竞,朱翠侠,陈坤.丙型肝炎病毒NS3蛋白酶在酵母系统中的可溶性表达[J].中国生物化学与分子生物学报,2005,21(2):209-214. 被引量:2
  • 8胡巍,刘文,宋晓国,朱翠侠,凌世淦.HCVNS5A-B片段的表达及在酶活性研究中的应用[J].细胞与分子免疫学杂志,2006,22(1):43-46. 被引量:5
  • 9Di Marco S, Rizzi M, Volpari C, et al. Inhibitor of the hepatitis C virus NS3/NS4A protease. J Biol Chem, 2000, 275(10): 7152- 7157. 被引量:1
  • 10Sudo K, Matsumoto Y, Matsushima M, et al. Novel hepatitis C virus protease inhibitors: thiazolidine derivatives. Biochem Biophys Res Commun, 1997, 238(2): 643-647. 被引量:1

二级参考文献9

共引文献36

同被引文献20

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部